GMP, GLP OR ISO 17025: HOW DO THESE APPLY TO OUTSOURCED ANALYTICAL TESTING?

Size: px
Start display at page:

Download "GMP, GLP OR ISO 17025: HOW DO THESE APPLY TO OUTSOURCED ANALYTICAL TESTING?"

Transcription

1 GMP, GLP OR ISO 17025: HOW DO THESE APPLY TO OUTSOURCED ANALYTICAL TESTING? Joe Grappin, MS, EAG Laboratories 2018 MD&M West Tech Theater 1

2 OVERVIEW Background: What Led to the Presentation History of the Regulations When and where the GLP s apply to Medical Device Testing? What is GMP testing and how does it apply to Medical Device Testing? What does ISO mean? Decision Tree Summary Questions 2

3 BACKGROUND: WHAT LED TO THE PRESENTATION My experience: Ten years of experience managing pharmaceutical container-closure testing in an analytical laboratory Seven years of experience managing and directing a medical device analytical testing laboratory Seven years of experience on the front line, selling laboratory testing capabilities to medical device clients What led to the Presentation? Clients frequently requested some answers to the following questions 3

4 CLIENT QUESTIONS Are you a GLP lab? Are you a GMP lab? Are you registered by the FDA? What type of quality system do you have in place? Are your instruments validated? What certifications do you have? Are you ISO certified? What is ISO 17025? 4

5 HISTORY OF THE REGULATIONS Good Laboratory Practices (GLP): Series of unfortunate events in 1960 s and 1970 s at pre-clinical (animal) laboratories Poor record-keeping Poorly designed studies Lack of oversite Animal resurrections 5

6 HISTORY OF THE REGULATIONS Determination by members of congress and the FDA that these laboratories were out of control. December 1978: FDA published final GLP regulations June 1979: Title 21 Food and Drugs of the Code of Federal Regulations (CFR) as Part 58. Good Laboratory Practice for Nonclinical Laboratory Studies Further changes to the GLP rules in 1984 and 1987: "Final Rule" - Compliance Program Bioresearch Monitoring: Good Laboratory Practices, which was expanded to incorporate the following: The requirement for a QA department The requirement for protocol preparation (study plan) The characterization of test and control materials The requirement to retain specimens and samples. 6

7 HISTORY OF THE REGULATIONS Good Manufacturing Practices (GMP) Developed in response to a series of problems involving the quality and safety of pharmaceuticals (drugs) 1930 s: Elixir of Sulfanilamide and sulfathiazole 1950 s and 1960 s: Polio vaccine and thalidomide The drug GMPs were established in 1963, expanded in 1978 and revised slightly in CFR Part 210: CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PROCESSING, PACKING, OR HOLDING OF DRUGS; GENERAL 21 CFR Part 211: CURRENT GOOD MANUFACTURING PRACTICE FOR FINISHED PHARMACEUTICALS 7

8 HISTORY OF THE REGULATIONS In 1978, when the Drug GMP s were expanded it was determined that Medical Device needed their own GMP s. Medical device manufacturing has a wide variety of processes when compared to pharmaceutical manufacturing Pharmaceutical products have biological activity where potency is critical. 21 CFR Part 820 Medical Devices, Quality System Regulations Revised in 1996 Harmonized with ISO 13485: Medical devices Quality management systems Requirements for regulatory purposes 8

9 HISTORY OF THE REGULATIONS Similarities and Differences between the Drug and Device GMP s Both are written describing general quality system requirements such as requiring the use of calibrated instruments for measurements. Drug GMP s go further in defining laboratory testing: 21CFR (b): Laboratory controls shall include the establishment of scientifically sound and appropriate specifications, standards, sampling plans, and test procedures designed to assure that components, drug product containers, closures, in-process materials, labeling, and drug products conform to appropriate standards of identity, strength, quality, and purity. 9

10 HISTORY OF THE REGULATIONS 21CFR (b): Laboratory controls shall include: Description of sampling plan, testing procedure and specifications Determination of conformance to specifications of in-process and drug products Calibration of instruments with limits of accuracy and precision defined 10

11 WHEN AND WHERE THE GLP S APPLY TO MEDICAL DEVICE TESTING Why wouldn t you want a lab to perform your test or study using good laboratory practices? The key is understanding why the GLP s were put in place to begin with: Control (or lack there of) in the pre-clinical laboratory Complex test systems, such as animal models or cell lines Observation-based 11

12 WHEN AND WHERE THE GLP S APPLY TO MEDICAL DEVICE TESTING Regulations define the scope of the GLP s Nonclinical laboratory study means in vivo or in vitro experiments in which test articles are studied prospectively in test systems under laboratory conditions to determine their safety. The term does not include studies utilizing human subjects or clinical studies or field trials in animals. The term does not include basic exploratory studies carried out to determine whether a test article has any potential utility or to determine physical or chemical characteristics of a test article. 12

13 WHEN AND WHERE THE GLP S APPLY TO MEDICAL DEVICE TESTING Questions to ask: 1. Is the study that I want to be performed use a test system as defined in 21 CFR part 58 (Animal model or cell line)? 2. Is the study considered exploratory and early stage investigational? Is the study not planning to be used in a submission? Prior to design freeze? 3. What if the study supports a corresponding GLP study? 4. Are there such things as non-glp studies? 13

14 WHEN AND WHERE THE GMP S APPLY TO MEDICAL DEVICE TESTING So your study does not fall under the GLP requirements Can I ask to have it done under GMP requirements? Answer: It depends Where is your study supporting in the Medical Device development process? 14

15 WHEN AND WHERE THE GMP APPLY TO MEDICAL DEVICE TESTING Questions to ask: 1. Is the study in support of an in-process inspection of a device or material? 21CFR Is the study in support of a process verification? 21CFR Is the material being tested the active pharmaceutical ingredient, excipient or container closure/delivery system of the drug-device combination product? 21CFR 210/ What if none of these scenarios apply? 15

16 WHEN AND WHERE THE GMP S APPLY TO MEDICAL DEVICE TESTING Is there enough direction in 21 CFR part 820 for the laboratory testing? 21CFR : Inspection, Measuring, and Test Equipment Control of inspection, measuring, and test equipment. Calibration Calibration standards Calibration records Applies to the manufacturing site and does not call out the details of what is acceptable. Is there another mechanism to ensure that my outsourced laboratory is producing results with a high level of scientific quality and would meet regulatory expectations? 17

17 WHAT IS ISO AND HOW DOES IT APPLY TO THE MEDICAL DEVICE INDUSTRY ISO General Requirements for the Competence of Testing and Calibration Laboratories. Main ISO standard used by testing and calibration laboratories. In most major countries, ISO/IEC is the standard for which most labs must hold accreditation in order to be deemed technically competent. The standard requires the use of certified calibration materials Trending of instrument data Competency of analysts Technique evaluated for the uncertainty of the measurements 18

18 WHAT IS ISO AND HOW DOES IT APPLY TO THE MEDICAL DEVICE INDUSTRY ISO General Requirements for the Competence of Testing and Calibration Laboratories. (Continued) Aligns with ISO and 21 CFR 820 in terms of quality management and documentation. Complements 21CFR part 58, not required Written specifically for laboratory operations If only performing GMP testing per 21 CFR 210/211, then ISO is not needed. Will FDA accept submission data from a ISO laboratory? ABSOLUTELY! 19

19 DECISION TREE 20

20 SUMMARY Not one set of regulations that covers every medical device testing situation. Applying the wrong regulation or standard could be detrimental to the overall time to market. The laboratory needs to provide scientific solutions that can meet the regulatory scrutiny of the industry. 21

21 QUESTIONS 22

22 THANK YOU Contact information: Joe Grappin EAG Laboratories 810 Kifer Road Sunnyvale, CA Phone:

23 THE POWER OF SCIENCE TO SHAPE COMMERCE How do you make a product better, easier to use or less expensive? How do you ensure regulatory compliance or strengthen your legal case? How do you bring powerful scientific know-how across materials sciences, engineering sciences and life sciences to your commercial challenges? Ask EAG. We Know How.

Method Validation Studies How GLP Interacts With Guidance Documents

Method Validation Studies How GLP Interacts With Guidance Documents Method Validation Studies How GLP Interacts With Guidance Documents Steven S. Kuwahara ROBERT GEORGE YOUNG/GETTY IMAGES GLP Forum addresses topics of interest associated with good laboratory practices.

More information

Overview of Good Food Laboratory Practices

Overview of Good Food Laboratory Practices Overview of Good Food Laboratory Practices Dr. Anne Bridges Technical Director, AACC International International Workshop & Training Program On Good Food Laboratory Practices Jointly Organized By Food

More information

GMP. Safeguard The Patient s Health.

GMP. Safeguard The Patient s Health. GMP Safeguard The Patient s Health. Scope. Products and testing according to pharma industry standard. Good Manufacturing Practice or GMP are practices and systems that are required to be adapted in pharmaceutical

More information

Course Outline for ISO 19011:2002 QMS & EMS Auditor

Course Outline for ISO 19011:2002 QMS & EMS Auditor Course objective Course Outline for ISO 19011:2002 QMS & EMS Auditor The auditor training program is based on ISO 19011:2002, which is a guideline document for auditing and implementing quality systems

More information

Test and Control Article Characterization for Medical Devices. Amy Schade, RQAP-GLP Director Corporate Compliance

Test and Control Article Characterization for Medical Devices. Amy Schade, RQAP-GLP Director Corporate Compliance for Amy Schade, RQAP-GLP Director Corporate Compliance Disclaimer» This presentation is not intended to encompass all of the requirements of the FDA, EPA, OECD or other regulatory programs for all types

More information

Effective Management and Operations of GXP Laboratories

Effective Management and Operations of GXP Laboratories Effective Management and Operations of GXP Laboratories Course Objective: Upon completion of this course, attendees involved in establishing and assuring that Good Laboratory / Good Manufacturing Practice

More information

"From Bedside to Bench and Back: regulatory requirements for collaborations between pharma industry and academia

From Bedside to Bench and Back: regulatory requirements for collaborations between pharma industry and academia "From Bedside to Bench and Back: regulatory requirements for collaborations between pharma industry and academia Damir Hamamdžić D.V.M., Ph.D. Office of Research Regulatory Affairs Rutgers University RWJMS

More information

A comparison of the complimentary and different issues in ISO/IEC and OECD GLP

A comparison of the complimentary and different issues in ISO/IEC and OECD GLP Accred Qual Assur (2003) 8:208 212 DOI 10.1007/s00769-003-0589-9 GENERAL PAPER Tina Engelhard Etty Feller Zahava Nizri A comparison of the complimentary and different issues in ISO/IEC 17025 and OECD GLP

More information

GMP Track 1 Day 2 Session 1 Vendor Assurance

GMP Track 1 Day 2 Session 1 Vendor Assurance GMP Track 1 Day 2 Session 1 Vendor Assurance 11 August 2015 150403_POUT This session Three presentations Chapter 6 and 7 - Trevor Schoerie Quality Control Out sourced Activities Draft - FDA Quality Metrics

More information

Cell Therapy Product Manufacturing Considerations. July 17, 2017 CMC Strategy Forum Mo Heidaran, Ph.D.

Cell Therapy Product Manufacturing Considerations. July 17, 2017 CMC Strategy Forum Mo Heidaran, Ph.D. Cell Therapy Product Manufacturing Considerations July 17, 2017 CMC Strategy Forum Mo Heidaran, Ph.D. Office of Tissues and Advanced Therapies FDA/CBER Overview Establishing Manufacturing Control Applying

More information

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY ISSN Review Article

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY  ISSN Review Article INTERNATIONAL RESEARCH JOURNAL OF PHARMACY www.irjponline.com ISSN 2230 8407 Review Article INTRODUCTION AND GENERAL OVERVIEW OF PHARMACEUTICAL PROCESS VALIDATION: A REVIEW Pandita Rachna* 1, Rana A C

More information

Quality Agreements with CMO s. Presented at ASQ Orange Empire Meeting May 13, 2014 By Luke Foo Sr. Director QA/QC Spectrum Pharmaceuticals

Quality Agreements with CMO s. Presented at ASQ Orange Empire Meeting May 13, 2014 By Luke Foo Sr. Director QA/QC Spectrum Pharmaceuticals Quality Agreements with CMO s Presented at ASQ Orange Empire Meeting May 13, 2014 By Luke Foo Sr. Director QA/QC Spectrum Pharmaceuticals FDA Guidance Contract Manufacturing Arrangements for Drugs: Quality

More information

1201 Maryland Avenue SW, Suite 900, Washington, DC ,

1201 Maryland Avenue SW, Suite 900, Washington, DC , 1201 Maryland Avenue SW, Suite 900, Washington, DC 20024 202-962-9200, www.bio.org February 22, 2011 Dockets Management Branch (HFA-305) Food and Drug Administration 5600 Fishers Lane, Rm. 1061 Rockville,

More information

Excipients Facing Increased Scrutiny How to Use Secondary Reference Standards to Help Maintain Regulatory Compliance

Excipients Facing Increased Scrutiny How to Use Secondary Reference Standards to Help Maintain Regulatory Compliance Excipients Facing Increased Scrutiny How to Use Secondary Reference Standards to Help Maintain Regulatory Compliance by Tom Savage, NSF International Since 2008, when patient deaths were first linked to

More information

Good Manufacturing Practice ( GMP ) Compliance: GMPs EXPLAINED

Good Manufacturing Practice ( GMP ) Compliance: GMPs EXPLAINED Good Manufacturing Practice ( GMP ) Compliance: GMPs EXPLAINED Presented by Raymond A. Bonner Nathan C. Sheers SIDLEY AUSTIN BROWN & WOOD, LLP Washington, D.C. (202) 736-8000 To The Fourth Annual Pharmaceutical

More information

Appropriate Control Strategies Eliminate the Need for Redundant Testing of Pharmaceutical Products

Appropriate Control Strategies Eliminate the Need for Redundant Testing of Pharmaceutical Products Date: April 23, 2012 Appropriate Control Strategies Eliminate the Need for Redundant Testing of Pharmaceutical Products Key Messages Importation quality control testing for pharmaceutical, biological/biotechnology

More information

Overview Everything You Wanted to Know About GLPs. but were afraid to ask

Overview Everything You Wanted to Know About GLPs. but were afraid to ask Overview Everything You Wanted to Know About GLPs. but were afraid to ask Janet Rose Christensen, M.S.P.H. Vice President, Regulatory Affairs and Quality AVI BioPharma, Inc. Portland, OR jrc@avibio.com/503.227.00554

More information

Calibration in the Laboratory

Calibration in the Laboratory IVT Validation Week 2015 Calibration in the Laboratory 2015 The Lanese Group, Inc. Jerry Lanese Ph.D. The Lanese Group, Inc. 1 Outline Overview of laboratory data integrity Elements of the Laboratory Instrument

More information

WARNING LETTER AUG 3, 2016

WARNING LETTER AUG 3, 2016 Ropack, Inc. 8/3/16 Department of Health and Human Services Public Health Service Food and Drug Administration 10903 New Hampshire Avenue White Oak Building 66 Silver Spring, MD 20993 WARNING LETTER AUG

More information

Phase Appropriate GMPs for IMPs. Presented by: Karen S. Ginsbury For: IFF, October 31, Nov 02, 2017

Phase Appropriate GMPs for IMPs. Presented by: Karen S. Ginsbury For: IFF, October 31, Nov 02, 2017 Phase Appropriate GMPs for IMPs Presented by: Karen S. Ginsbury For: IFF, October 31, Nov 02, 2017 1 Lets start with References https://mhrainspectorate.blog.gov.uk/2016/0 5/20/manufacture-of-investigationalmedicinal-products-frequently-askedquestions/

More information

Bioresearch Monitoring Inspections in Vitro Diagnostics Devices

Bioresearch Monitoring Inspections in Vitro Diagnostics Devices Seite 1 von 7 U.S. Food and Drug Administration Protecting and Promoting Your Health Bioresearch Monitoring Inspections in Vitro Diagnostics Devices TABLE OF CONTENTS Introduction Nature, Scope, & Purpose

More information

Perspective: New European IVD Regulations New Concepts for Market Authorizations and Product Launch Schedules

Perspective: New European IVD Regulations New Concepts for Market Authorizations and Product Launch Schedules Perspective: New European IVD Regulations New Concepts for Market Authorizations and Product Launch Schedules Planning for Efficiencies of Data, Resources, and Timelines A PRECISION BRIEF Introduction

More information

Library Guide: Active Pharmaceutical

Library Guide: Active Pharmaceutical Library Guide: Active Pharmaceutical Ingredients (API) Table of Contents Overview...3 Sample Curriculum...5 Course Descriptions: A Step-by-Step Approach to Process Validation (PHDV79)...7 A Tour of the

More information

Validation/Verification of Test Methods An FDA Perspective. Laure H. Kairawicz, Ph.D. Senior Scientist Expert Witness

Validation/Verification of Test Methods An FDA Perspective. Laure H. Kairawicz, Ph.D. Senior Scientist Expert Witness Validation/Verification of Test Methods An FDA Perspective Laure H. Kairawicz, Ph.D. Senior Scientist Expert Witness FD & C Act Overview Definition of drugs What cgmps are Finished Pharmaceuticals cgmp

More information

Pharmaceutical Reference Standards: Overview and Role in Global Harmonization

Pharmaceutical Reference Standards: Overview and Role in Global Harmonization Matthew Borer, Ph.D., Advisor Pharmaceutical Reference Standards: Overview and Role in Global Harmonization 3rd DIA China Annual Meeting Beijing, China, 16-18 May, 2011 What is a Pharmaceutical Reference

More information

GLP/SC/01 Basic statistical tools for analytical chemistry (2 days)

GLP/SC/01 Basic statistical tools for analytical chemistry (2 days) GLP Consulting http://consultglp.com Courses on offer (See outlines below) GLP/SC/01 Basic statistical tools for analytical chemistry (2 days) GLP/SC/02 The GUM bottom-up evaluation technique of measurement

More information

PART 58 GOOD LABORATORY PRACTICE FOR NONCLINICAL LABORATORY STUDIES

PART 58 GOOD LABORATORY PRACTICE FOR NONCLINICAL LABORATORY STUDIES Part 58-explanation of changes Scope ( 58.1) We propose to expand the scope of FDA-regulated nonclinical laboratory studies to specifically include toxicity studies. For purposes of this proposal, toxicity

More information

PART 58 GOOD LABORATORY PRACTICE FOR NONCLINICAL LABORATORY STUDIES

PART 58 GOOD LABORATORY PRACTICE FOR NONCLINICAL LABORATORY STUDIES Part 58-explanation of changes Scope ( 58.1) We propose to expand the scope of FDA-regulated nonclinical laboratory studies to specifically include toxicity studies. For purposes of this proposal, toxicity

More information

Available online at ScienceDirect. Procedia Engineering 132 (2015 )

Available online at  ScienceDirect. Procedia Engineering 132 (2015 ) Available online at www.sciencedirect.com ScienceDirect Procedia Engineering 132 (2015 ) 811 815 The Manufacturing Engineering Society International Conference, MESIC 2015 Metrological Regulations for

More information

Synopsis: FDA Process Validation Guidance

Synopsis: FDA Process Validation Guidance Synopsis: FDA Process Validation Guidance This synopsis is a comparison of the draft version 2008 and the final version 2011 of the U.S. FDA Guidance Process Validation: General Principles and Practices.

More information

At Your ServIce. Microbiology Services. The life science business of Merck operates as MilliporeSigma in the U.S. and Canada.

At Your ServIce. Microbiology Services. The life science business of Merck operates as MilliporeSigma in the U.S. and Canada. At Your ServIce Microbiology Services The life science business of Merck operates as MilliporeSigma in the U.S. and Canada. Microbiology Services Optimize your QC lab workflow and ensure regulatory compliance

More information

Drug Quality Assurance: Systems at ChemCon Author: Dr. Peter Gockel

Drug Quality Assurance: Systems at ChemCon Author: Dr. Peter Gockel Drug Quality Assurance: Systems at ChemCon Author: Dr. Peter Gockel On February 13th, 2006, the FOOD AND DRUG ADMINISTRATION (FDA) implemented a revision to the Compliance Program Guidance Manual for active

More information

While the recognition

While the recognition Designing the Perfect Change Control System Change control systems today are expected to be designed in a way that provides a system to not only document and approve changes, but also to anticipate change

More information

Incremental GMPs. Presented by: Karen S. Ginsbury For: IFF October 31, Nov 02, PCI Pharmaceutical Consulting Israel Ltd.

Incremental GMPs. Presented by: Karen S. Ginsbury For: IFF October 31, Nov 02, PCI Pharmaceutical Consulting Israel Ltd. Incremental GMPs Presented by: Karen S. Ginsbury For: IFF October 31, Nov 02, 2017 1/55 Sound Science Good Development Practice Traceability R&D Tox I II III IV What You Need Here Can t be generated here

More information

Medical Device Communiqué

Medical Device Communiqué Medical Device Communiqué Q2 2013 Demonstrating the Safety of Medical Devices in the Human Body 1 DOJ: The Focus is on GMPs in 2013 2 ROHS II Impacts Medical Device Companies 3 Demonstrating the Safety

More information

Quality Issues for Clinical Trial Materials: The Chemistry, Manufacturing and Controls (CMC) Review

Quality Issues for Clinical Trial Materials: The Chemistry, Manufacturing and Controls (CMC) Review Quality Issues for Clinical Trial Materials: The Chemistry, Manufacturing and Controls (CMC) Review Presented by Erika E. Englund, Ph.D. Slides courtesy of Dorota Matecka, Ph.D. Office of Pharmaceutical

More information

INVESTIGATIONAL DEVICE EXEMPTION APPLICATION. IDE Title (if title being used)

INVESTIGATIONAL DEVICE EXEMPTION APPLICATION. IDE Title (if title being used) INVESTIGATIONAL DEVICE EXEMPTION APPLICATION IDE Title (if title being used) Name of Sponsor Investigator, MD X Professor, Department Icahn School of Medicine at Mount Sinai Date of Submission Form version

More information

Christine Oechslein. GMP Focus. Managing Process Validation. A Drugmaker s Guide. PDF Download. Excerpt from the GMP MANUAL

Christine Oechslein. GMP Focus. Managing Process Validation. A Drugmaker s Guide. PDF Download. Excerpt from the GMP MANUAL Christine Oechslein GMP Focus Managing Process Validation A Drugmaker s Guide PDF Download Excerpt from the GMP MANUAL Bibliographic Data of the Deutsche Nationalbibliothek: http://dnb.ddb.de ISBN: 978-3-95807-056-1

More information

Q10 PHARMACEUTICAL QUALITY SYSTEM

Q10 PHARMACEUTICAL QUALITY SYSTEM Q10 PHARMACEUTICAL QUALITY SYSTEM This draft guidance, when finalized, will represent the Food and Drug Administration's (FDA's) current thinking on this topic. It does not create or confer any rights

More information

ICH Q8/Q8(R)

ICH Q8/Q8(R) Pharmaceutical Quality for the 21 st Century Temple University May 06, 2008 Joseph Famulare, Deputy Director FDA CDER Office of Compliance CDER Office of Compliance and the Critical Path Initiative Since

More information

Auditing Your Laboratory for Compliance with the FDA Dietary Supplement GMP s

Auditing Your Laboratory for Compliance with the FDA Dietary Supplement GMP s Tech Tip 0020 With the advent of the cgmp s, the majority of companies are increasing the frequency of their outsourced analytical testing. But the GMPs are just that, Good Manufacturing Practices, and

More information

PDA & West Present: Combination Products Combination Product Hot Topics: Post Approval Device Changes and the New EU MDR Article 117 Requirements

PDA & West Present: Combination Products Combination Product Hot Topics: Post Approval Device Changes and the New EU MDR Article 117 Requirements PDA & West Present: Combination Products Combination Product Hot Topics: Post Approval Device Changes and the New EU MDR Article 117 Requirements Doug Mead, Sr. Director, CMC RA, Devices and Combination

More information

Key Elements of Quality Assurance in the Good Laboratory Practice (GLP) Environment

Key Elements of Quality Assurance in the Good Laboratory Practice (GLP) Environment Key Elements of Quality Assurance in the Good Laboratory Practice (GLP) Environment The principles of Good Laboratory Practice (GLP) define a set of rules and criteria for a quality system concerned with

More information

CGMP Requirements for Investigational Products

CGMP Requirements for Investigational Products PREP #6 CGMP Requirements for Investigational Products Ji-Eun Kim, RPh, PhD Research Pharmacist Regulatory Affairs Office of Research Compliance December 6, 2016 1 CME Disclosure Statement Northwell Health

More information

EU and FDA GMP Regulations: Overview and Comparison

EU and FDA GMP Regulations: Overview and Comparison THE QUALITY ASSURANCE JOURNAL, VOL. 2, 55 60 (1997) EU and FDA GMP Regulations: Overview and Comparison The increasing emphasis on global supply of drug products, as well as starting materials and investigational

More information

Food Contaminants and Residue Analysis

Food Contaminants and Residue Analysis Food Contaminants and Residue Analysis by Yolanda Picó Laboratori de Bromatologia i Toxicologia, Facultat de Farmàcia, Universitat de València, 46100 Burjassot, València, Spain. Publisher: Elsevier Science

More information

An Urgent Bulletin from CSA Group

An Urgent Bulletin from CSA Group Ref No: I18-086 Verification Service Announcement No. 78 Date: June 27, 2018 An Urgent Bulletin from CSA Group New Verification Service available as of today Apply any time to have your products evaluated

More information

Paving the way to FDA? tips and pitfalls. The Nextar start up support program Dr. Orna Dreazen- CEO

Paving the way to FDA? tips and pitfalls. The Nextar start up support program Dr. Orna Dreazen- CEO Paving the way to FDA? tips and pitfalls The Nextar start up support program Dr. Orna Dreazen- CEO ornad@nextar.co.il Drug Development Process Discovery Development Commercial Market Basic Research Pre-Clinical

More information

Your partner in the pharmaceutical industry

Your partner in the pharmaceutical industry English Micronisation- and milling service Micronised by GfM Your API Particle size (µm) Your partner in the pharmaceutical industry The... always that little bit finer. We are a family business in the

More information

Compliance and qualification services. Trust your validation needs to the people who design, build, test, and support your systems

Compliance and qualification services. Trust your validation needs to the people who design, build, test, and support your systems Compliance and qualification services Trust your validation needs to the people who design, build, test, and support your systems Validation can be challenging If your laboratory is required to qualify

More information

GxP Auditing, Remediation, and Quality System Resourcing

GxP Auditing, Remediation, and Quality System Resourcing GxP Auditing, Remediation, and Quality System Resourcing TABLE OF CONTENTS 3 Introduction 4 GxP Auditing 4 GMP Auditing 5 GCP Auditing 6 GLP Auditing 7 Pharmacovigilance Auditing 7 Vendor/Supplier Auditing

More information

Life Sciences Courseware. Knowledge. Performance. Impact.

Life Sciences Courseware. Knowledge. Performance. Impact. Life Sciences Courseware Knowledge. Performance. Impact. Now there s a flexible, affordable way to achieve your compliance training goals. In the Life Sciences industry, it s vital that your people are

More information

Regulations in Pharmaceutical Laboratories

Regulations in Pharmaceutical Laboratories Regulations in Pharmaceutical Laboratories February 2004 Ludwig Huber Compliance Fellow for Life Sciences and Chemical Analysis Chairperson: Rob Sample Regulations and Quality Standards Developed by Industries

More information

Notes from Round Table 5. January 26 and 27, 2016

Notes from Round Table 5. January 26 and 27, 2016 Notes from Round Table 5 January 26 and 27, 2016 Topic: Facilitator: Scribe: Potency Assays: Cell Based vs. Non Cell Based Formats Sally Seaver, Seaver Associates LLC Cheryl Blaise, Bristol-Myers Squibb

More information

Regula'on of Contracep'ves

Regula'on of Contracep'ves Regula'on of Contracep'ves VETERINARY DRUG DEVELOPMENT: REGULATION OF STERILANTS AND CONTRACEPTIVES David M. Petrick, VMD, JD The Delta Consortium Regulatory Consulting Limited Copyright July, 2018 Veterinary

More information

Navigating an FDA GMP and Validation Inspection- Best Practices and Pitfalls

Navigating an FDA GMP and Validation Inspection- Best Practices and Pitfalls Navigating an FDA GMP and Validation Inspection- Best Practices and Pitfalls Sonali P. Gunawardhana FDA Practice Group Wiley Rein LLP 1776 K Street NW Washington, DC (202) 719-7454 sgunawardhana@wileyrein.com

More information

OUT OF SPECIFICATION. SASIDA YOOSOOK 4 April 2014

OUT OF SPECIFICATION. SASIDA YOOSOOK 4 April 2014 OUT OF SPECIFICATION SASIDA YOOSOOK 4 April 2014 ISO 17025:2005 4.9 Control of nonconforming testing and/or calibration work 4.9.1 The laboratory shall have a policy and procedures that shall be implemented

More information

Research Professionals Network Workshop Series

Research Professionals Network Workshop Series Research Professionals Network Workshop Series SO YOU THINK YOU KNOW GCP? Mary-Tara Roth Director, CRRO mtroth@bu.edu Gina Daniels Human Research Quality Manager gdaniels@bu.edu What is [ICH] GCP? an

More information

Inspection Trends. American Society for Quality Richmond, VA Section March 8, 2016

Inspection Trends. American Society for Quality Richmond, VA Section March 8, 2016 Inspection Trends American Society for Quality Richmond, VA Section March 8, 2016 Brooke K. Higgins, Senior Policy Advisor CDER / Office of Compliance Office of Manufacturing Quality Division of Drug Quality

More information

Manual 055 Commercial Stability Testing For Formulated Products. This procedure applies to all drug products. The procedure covers:

Manual 055 Commercial Stability Testing For Formulated Products. This procedure applies to all drug products. The procedure covers: 1 Purpose Manual 055 Commercial Stability Testing For Formulated Products The intent of this procedure is to provide to manufacturing and primary packaging sites the principles of a stability program.

More information

ICH Q10/WHO TRS A Regulatory Perspective

ICH Q10/WHO TRS A Regulatory Perspective Presentation by: Dr. A. Ramkishan Asst. Drugs Controller (India) Govt. of India ICH Q10/WHO TRS A Regulatory Perspective Contents of Presentation Introduction History of WHO GMP TRS guidelines A Unique

More information

Stability Studies for Pharmaceutical Products (API and finished products)

Stability Studies for Pharmaceutical Products (API and finished products) A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program Shaping Human Capital for Challenges in the Pharmaceutical Industry Stability Studies for Pharmaceutical Products (API and finished products)

More information

THE COMPLETE GUIDE TO FDA-REGULATED SUPPLIER QUALIFICATION & QUALITY MANAGEMENT

THE COMPLETE GUIDE TO FDA-REGULATED SUPPLIER QUALIFICATION & QUALITY MANAGEMENT THE COMPLETE GUIDE TO FDA-REGULATED SUPPLIER QUALIFICATION & QUALITY MANAGEMENT A risk-based approach to qualifying, managing and auditing third party providers TABLE OF CONTENTS 1 Outsourcing under greater

More information

Left to Our Own Devices Design Control & Risk Management Strategies for Combination Products

Left to Our Own Devices Design Control & Risk Management Strategies for Combination Products Left to Our Own Devices Design Control & Risk Management Strategies for Combination Products DR. RICK WEDGE 12 MAR 2018 Overview Definitions Current Regulatory Landscape Design Controls Risk Management

More information

V&V Best Practices. CASSS, CMC Strategy Forum Steven W. Badelt, PhD Managing Partner Suttons Creek, Inc. SUTTONSCREEK.COM

V&V Best Practices. CASSS, CMC Strategy Forum Steven W. Badelt, PhD Managing Partner Suttons Creek, Inc. SUTTONSCREEK.COM V&V Best Practices CASSS, CMC Strategy Forum Steven W. Badelt, PhD Managing Partner Suttons Creek, Inc. Solving the problem of Complexity. 21CFR820.30 & FDA Guidance INCOSE System Engineering Handbook

More information

Where Quality Meets Flexibility

Where Quality Meets Flexibility Where Quality Meets Flexibility is an industry leading 503B Outsourcing Facility providing sterile and non-sterile compounding services to hospitals, surgery centers, clinics, researchers & patients nationwide.

More information

Harmonization day 2015 FSSC audit reporting

Harmonization day 2015 FSSC audit reporting Harmonization day 2015 FSSC 22000 audit reporting Today s topics 1. Basics audit reporting 2. Definition audit report 3. Audit report requirements 4. Conclusions 1. Basics audit reporting Starting point

More information

TURBO MACH A DIVISION OF VT SAA

TURBO MACH A DIVISION OF VT SAA TERMS AND CONDITIONS PAGE: 1 OF 5 1. PURPOSE To define specific terms and conditions for the purchase of product, materials and services. 2. SCOPE All products, materials and services purchased for use

More information

Data Quality and Integrity: From Clinical Monitoring to Marketing Approval

Data Quality and Integrity: From Clinical Monitoring to Marketing Approval Data Quality and Integrity: From Clinical Monitoring to Marketing Approval Nancy Detich, Ph.D., C.C.R.P. Senior Scientist, Clinical Strategy 18 November 2010 1 Objectives Identify the importance of accuracy,

More information

EFFECTIVE PROCESS VALIDATION NUSAGE PharmEng Pharmaceutical and Biotechnology Training Program Copyright 2014 NUSAGE-PharmEng.

EFFECTIVE PROCESS VALIDATION NUSAGE PharmEng Pharmaceutical and Biotechnology Training Program   Copyright 2014 NUSAGE-PharmEng. EFFECTIVE PROCESS VALIDATION NUSAGE PharmEng Pharmaceutical and Biotechnology Training Program Shaping Human Capital for Challenges in the Pharmaceutical Industry EFFECTIVE PROCESS VALIDATION Objective

More information

FOREIGN DRUG INSPECTION/AUDITS FROM THE FDA PERSPECTIVE

FOREIGN DRUG INSPECTION/AUDITS FROM THE FDA PERSPECTIVE FOREIGN DRUG INSPECTION/AUDITS FROM THE FDA PERSPECTIVE Robert C. Fish EAS Consulting Group, LLC. Statistics About 80% of world supply of APIs from India and China Some API produced in Korea, but little

More information

International Journal of Pharmaceutical and Medicinal Research

International Journal of Pharmaceutical and Medicinal Research Review article A review on process validation Int. J. Pharm. Med. Res. 2014; 2(3):100-104 ISSN: 2347-7008 International Journal of Pharmaceutical and Medicinal Research Journal homepage: www.ijpmr.org

More information

GxP Auditing, Remediation, and Staff Augmentation

GxP Auditing, Remediation, and Staff Augmentation GxP Auditing, Remediation, and Staff Augmentation TABLE OF CONTENTS 3 Introduction 4 GxP Auditing 4 GMP Auditing 5 GCP Auditing 5 GLP Auditing 6 Pharmacovigilance Auditing 6 Vendor/Supplier Auditing 7

More information

COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS

COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS Primer CONTENTS INTRODUCTION...3 QUALITY AND COMPLIANCE IN QUALITY CONTROL LABORATORIES...5 Compliance

More information

Subpart B Organization and Personnel, 21 CFR Responsibilities of the quality control unit.

Subpart B Organization and Personnel, 21 CFR Responsibilities of the quality control unit. FDA inspections continue to focus on CGMP violations related to basic GMP controls. A survey of Warning Letters issued in 2013 on CMC (Chemistry / Manufacturing / Controls) violations reveals an emphasis

More information

PACIFIC RIM CONSULTING COMMENTS ON FDA PROPOSAL TO REVISE GLPS

PACIFIC RIM CONSULTING COMMENTS ON FDA PROPOSAL TO REVISE GLPS PACIFIC RIM CONSULTING COMMENTS ON FDA PROPOSAL TO REVISE GLPS 1. GLP Quality System While many of the requirements of the existing regulation are consistent with a GLP quality system, FDA believes that

More information

Establishment of an Accredited Reference Measurement Laboratory

Establishment of an Accredited Reference Measurement Laboratory Establishment of an Accredited Reference Measurement Laboratory Francesco Dati, PhD IVD-Consulting Marburg / Germany E-mail: f.dati@t-online.de Quality of Analytical Systems Reference Measurement Systems

More information

A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program

A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program Shaping Human Capital for Challenges in the Pharmaceutical Industry EFFECTIVE PROCESS VALIDATION Instructor Rick Ng Date and Time 10-11

More information

San Jose, California, USA

San Jose, California, USA Glisland, Inc. San Jose, California, USA http://www.glisland.com Welcome to the Drug GMP World Current Good Manufacturing Practice cgmp ICH Q10 Pharmaceutical Quality System PQS GMP QSR Quality System

More information

Performing Multiple Regulatory Requirements within a Program Such as GMP, GLP, GCP, Medical Devices, and/or Controlled Substances

Performing Multiple Regulatory Requirements within a Program Such as GMP, GLP, GCP, Medical Devices, and/or Controlled Substances Performing Multiple Regulatory Requirements within a Program Such as GMP, GLP, GCP, Medical Devices, and/or Controlled Substances Performing Multiple Regulatory Requirements within a Program Such as GMP,

More information

Jeff Yuen and Associates, Inc. PO Box 6026 Orange, CA Zenaida Power Regulatory Expertise:

Jeff Yuen and Associates, Inc. PO Box 6026 Orange, CA Zenaida Power Regulatory Expertise: Regulatory Expertise: Pharmaceuticals: Sterile-Liquids, Non-Sterile Liquids, Solid Oral Dosage Form, Parenterals, Antibiotics, APIs/Bulk Chemicals, Creams & Ointments Medical Devices: Implantable / Active

More information

Contents. Contents (13) 1 Production (23)

Contents. Contents (13) 1 Production (23) 1 Production (23) 1.A Sanitation (27) 1.A.1 Organisational prerequisites (27) 1.A.2 Sources of contamination (28) 1.A.3 Responsibilities and implementation (29) 1.B Personnel hygiene (31) 1.B.1 Clothing

More information

Risk Based Incoming Quality Assurance (IQA)

Risk Based Incoming Quality Assurance (IQA) Microrite, Inc. brings you this unique learning experience in Risk Based Incoming Quality Assurance (IQA); Part of Microrite s step-by-step webinar series. Risk Based Incoming Quality Assurance (IQA) In

More information

Lachman Consultant Services, Inc., 1600 Stewart Avenue, Westbury, NY 11590, USA

Lachman Consultant Services, Inc., 1600 Stewart Avenue, Westbury, NY 11590, USA Current Challenges for FDA-Regulated Bioanalytical Laboratories for Human (BA/BE) Studies. Part I: Defining the Appropriate Compliance Standards Application of the Principles of FDA GLP and FDA GMP to

More information

National Animal Supplement Council

National Animal Supplement Council NASC established a Preferred Supplier Program for companies who wish to provide products and services to NASC member companies, including raw materials (ingredients), contract manufacturing (dosage form

More information

Thank You to United States Pharmacopeia for Their Sponsorship and Assistance

Thank You to United States Pharmacopeia for Their Sponsorship and Assistance Use of Measurement Uncertainty in Testing a Drug Substance M.L. Jane Weitzel Quality Analysis Consultants mljweitzel@msn.com Eurachem/CITAC Workshop June 2011 Thank You to United States Pharmacopeia for

More information

Control strategy and validation. Emanuela Lacana PhD Office of Biotechnology Products CDER/FDA

Control strategy and validation. Emanuela Lacana PhD Office of Biotechnology Products CDER/FDA Control strategy and validation Emanuela Lacana PhD Office of Biotechnology Products CDER/FDA 1 Disclaimer The views and opinions expressed in this presentation are those of the speaker and should not

More information

PROCESS VALIDATION ROCHAPON WACHAROTAYANKUN, PH.D.

PROCESS VALIDATION ROCHAPON WACHAROTAYANKUN, PH.D. Basic GMP Requirement PROCESS VALIDATION ROCHAPON WACHAROTAYANKUN, PH.D. Topic Process validation What and Why? Principle of process validation Manufacturing process validation Aseptic process validation

More information

PAT & Risk-Based Initiatives: Implementation Issues PDA New England - 8 th Dec Cliff Campbell B.E., C.Eng. CC&A Ltd., Cork, Ireland

PAT & Risk-Based Initiatives: Implementation Issues PDA New England - 8 th Dec Cliff Campbell B.E., C.Eng. CC&A Ltd., Cork, Ireland PAT & Risk-Based Initiatives: Implementation Issues PDA New England - 8 th Dec 2004 Cliff Campbell B.E., C.Eng. CC&A Ltd., Cork, Ireland cca@iol.ie 1 FDA Context 1) FDA 5-Part Strategic Plan Protect &

More information

Textvergleich. Verglichene Dokumente MEDIA3917.pdf. ICH_Q10_Step4.pdf

Textvergleich. Verglichene Dokumente MEDIA3917.pdf. ICH_Q10_Step4.pdf Textvergleich Verglichene Dokumente MEDIA3917.pdf ICH_Q10_Step4.pdf Übersicht 2270 Wort/Wörter hinzugefügt 1338 Wort/Wörter gelöscht 3558 Wort/Wörter übereinstimmend 157 Block/Blöcke übereinstimmend Blättern

More information

INTRODUCTION TO THE QUALITY SYSTEMS APPROACH TO CGMP COMPLIANCE

INTRODUCTION TO THE QUALITY SYSTEMS APPROACH TO CGMP COMPLIANCE 001_005.qxd 24/2/06 19:46 Page 1 CHAPTER 1 INTRODUCTION TO THE QUALITY SYSTEMS APPROACH TO CGMP COMPLIANCE 1.1 OVERVIEW OF QUALITY SYSTEMS The Food and Drug Administration (FDA) mandates that a drug firm,

More information

General Accreditation Criteria Equipment assurance, in-house calibration and equipment verification

General Accreditation Criteria Equipment assurance, in-house calibration and equipment verification General Accreditation Criteria Equipment assurance, in-house calibration and equipment verification January 2018 Copyright National Association of Testing Authorities, Australia 2009 This publication is

More information

Changes without Prior Approval

Changes without Prior Approval Changes without Prior Approval Breakout Session Summary Rick Smith Aventis Pasteur, Inc. Issues Discussed Risk Analysis for Post Approval Changes Comparability Protocols Development Reports Other Risk-Based

More information

OCTC 2012 CRO Selection

OCTC 2012 CRO Selection OCTC 2012 CRO Selection Colin Macaulay Viron Therapeutics Inc. 15 Nov 2012 Viron Therapeutics Inc. Virtual Biotech Company (6) Phase 2a (48 pt) clinical trial in acute coronary syndrome (ACS) completed

More information

The Importance of Supplier Qualification of the Full Distribution Life-cycle in Pharmaceuticals

The Importance of Supplier Qualification of the Full Distribution Life-cycle in Pharmaceuticals The Importance of Supplier Qualification of the Full Distribution Life-cycle in Pharmaceuticals William Dale Carter IPEC Americas Chair-Elect & GMP Committee Chair ExcipientFest April 25, 2012 www.ipecamericas.org

More information

Inspections, Compliance, Enforcement, and Criminal Investigations

Inspections, Compliance, Enforcement, and Criminal Investigations Seite 1 von 8 Inspections, Compliance, Enforcement, and Criminal Investigations Department of Health and Human Services Public Health Service Food and Drug Administration Center for Biologics Evaluation

More information

QUALITY AGREEMENT. The following Agreement has been concluded between

QUALITY AGREEMENT. The following Agreement has been concluded between QUALITY AGREEMENT The following Agreement has been concluded between LLC LABORATORIES The contract laboratory and service provider 1625 Trinity Dr., Unit 11 Mississauga, Ontario Canada L5T 1W9 Hereinafter

More information

Quality Assurance in Pharmaceutical and Biotech Industries as Per Regulatory Guidelines

Quality Assurance in Pharmaceutical and Biotech Industries as Per Regulatory Guidelines Human Journals Review Article January 2017 Vol.:8, Issue:2 All rights are reserved by Chagi Venkatesh et al. Quality Assurance in Pharmaceutical Biotech Industries as Per Regulatory Guidelines Keywords:

More information

CUSTOMER AND SUPPLIER ROLES AND RESPONSIBILITIES FOR 21 CFR 11 COMPLIANCE ASSESSMENT. 21 CFR Part 11 FAQ. (Frequently Asked Questions)

CUSTOMER AND SUPPLIER ROLES AND RESPONSIBILITIES FOR 21 CFR 11 COMPLIANCE ASSESSMENT. 21 CFR Part 11 FAQ. (Frequently Asked Questions) 21 CFR Part 11 FAQ (Frequently Asked Questions) Customer and Supplier Roles and Responsibilities for Assessment of METTLER TOLEDO STARe Software Version 16.00, including: - 21 CFR 11 Compliance software

More information